. .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. . . . follow @dailymail .president trump tweeted monday that she "is doing really well" and would be leaving the hospital in "2 or 3 days" after her procedure. . $17 OFF DEAL Save $17 off sitewide Birthday Collections From $17 @ Cosmetics Promo Codes 100% Success share 218 Used Today 50% OFF DEAL Up to 50% Off Velvet Lip Kits 100% Success share GET DEAL 181 Used Today $20 OFF DEAL $20 off all orders Brushes From $20 @ Cosmetics Promo Codes 100% Success share GET DEAL 200 Used Today